Sarepta Therapeutics Financial Ratios
NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Sarepta Therapeutics ratio analysis
Sarepta Therapeutics earned a net margin of -32.5% in FY 2025, down from 12.4% a year earlier. Gross margin was 98.8% compared with a median of 97.6% over the prior 1 years. Return on equity reached -62.5%, meaning Sarepta Therapeutics generated -0.63 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.73 versus 0.74 the year before, and the current ratio was 2.32. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Sarepta Therapeutics financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | — | 53.97 | — | — | — | — | — | — | — | — |
| Price / sales | 0.97 | 6.31 | 7.17 | 12.16 | 10.43 | 24.61 | 25.09 | 25.40 | 21.17 | 246.40 |
| Price / book | 1.87 | 7.86 | 10.37 | 29.47 | 7.89 | 17.45 | 11.68 | 7.41 | 4.15 | 3.97 |
| Gross margin | 98.8% | — | — | — | — | — | — | — | — | 97.6% |
| Operating margin | -31.8% | 11.5% | -21.5% | -57.5% | -65.5% | -104.5% | -185.3% | -114.1% | -111.0% | -4,920.3% |
| Net margin | -32.5% | 12.4% | -43.1% | -75.4% | -59.7% | -102.6% | -187.8% | -120.2% | -32.8% | -4,930.2% |
| Free cash flow margin | -14.0% | -18.0% | -46.4% | -38.2% | -68.6% | 4.7% | -135.5% | -149.4% | -157.8% | -4,633.1% |
| Return on equity (ROE) | -62.5% | 15.4% | -62.4% | -182.7% | -45.1% | -72.7% | -87.4% | -35.1% | -6.4% | -79.4% |
| Return on assets (ROA) | -21.3% | 5.9% | -16.4% | -22.5% | -13.3% | -18.6% | -39.2% | -22.0% | -3.9% | -63.0% |
| Debt / equity | 0.73 | 0.74 | 1.56 | 4.01 | 0.61 | — | — | 0.41 | 0.55 | 0.05 |
| Current ratio | 2.32 | 4.20 | 3.95 | 4.13 | 5.75 | 5.97 | 5.55 | 8.21 | 13.91 | 4.95 |
| Revenue growth | 15.6% | 53.0% | 33.3% | 32.9% | 30.0% | 41.8% | 26.5% | 94.7% | 2,751.6% | 332.6% |
| EPS growth | -404.7% | — | — | — | — | — | — | — | — | — |